These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 7655378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment.
    Klumpp TR, Goldberg SL, Magdalinski AJ, Mangan KF.
    Bone Marrow Transplant; 1997 Aug; 20(4):273-81. PubMed ID: 9285541
    [Abstract] [Full Text] [Related]

  • 3. [High-dosage chemotherapy and the autologous transplantation of peripheral hematopoietic progenitor cells in breast cancer: the initial results, analysis of toxicity and the necessary support means].
    Sola Rocabert C, Mesía R, Mendoza L, Tabernero JM, Amill B, Maroto P, Bellet M, Ojeda B, Alonso MC, Verger G.
    Med Clin (Barc); 1995 Oct 07; 105(11):407-11. PubMed ID: 7475451
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma.
    Fontelonga A, Kelly AJ, MacKintosh FR, Hall S, Monroe P, Wilson GS, Shaft D, Ruthven A, Ascensao JL.
    Bone Marrow Transplant; 1997 May 07; 19(10):983-8. PubMed ID: 9169642
    [Abstract] [Full Text] [Related]

  • 6. High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial.
    Stiff PJ, Bayer R, Tan S, Camarda M, Sosman J, Peace D, Kinch L, Rad N, Loutfi S.
    Clin Cancer Res; 1995 Dec 07; 1(12):1495-502. PubMed ID: 9815949
    [Abstract] [Full Text] [Related]

  • 7. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
    Schrama JG, Baars JW, Holtkamp MJ, Schornagel JH, Beijnen JH, Rodenhuis S.
    Bone Marrow Transplant; 2001 Jul 07; 28(2):173-80. PubMed ID: 11509935
    [Abstract] [Full Text] [Related]

  • 8. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.
    Zimmerman TM, Grinblatt DL, Malloy R, Williams SF.
    Cancer; 1998 Oct 15; 83(8):1540-5. PubMed ID: 9781947
    [Abstract] [Full Text] [Related]

  • 9. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
    Shi Y, Pan F, Han X.
    Zhonghua Yi Xue Za Zhi; 1999 Dec 15; 79(12):890-3. PubMed ID: 11715500
    [Abstract] [Full Text] [Related]

  • 10. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.
    Demirer T, Uysal VA, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Ozet G, Muftuoglu O, Akan H.
    Bone Marrow Transplant; 2003 May 15; 31(9):755-61. PubMed ID: 12732881
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates.
    Meehan KR, Verma UN, Cahill R, Frankel S, Areman EM, Sacher RA, Foelber R, Rajagopal C, Gehan EA, Lippman ME, Mazumder A.
    Bone Marrow Transplant; 1997 Oct 15; 20(8):643-51. PubMed ID: 9383227
    [Abstract] [Full Text] [Related]

  • 12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 15; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 13. High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
    deMagalhaes-Silverman M, Bloom E, Lembersky B, Lister J, Pincus S, Rybka W, Voloshin M, Wilson J, Ball E.
    Clin Cancer Res; 1997 Feb 15; 3(2):193-7. PubMed ID: 9815672
    [Abstract] [Full Text] [Related]

  • 14. Results of a pilot study of 40 patients using high-dose therapy with hematopoietic rescue after standard-dose adjuvant therapy for high-risk breast cancer.
    Tomás JF, Pérez-Carrión R, Escudero A, López-Lorenzo JL, López-Pascual J, Fernández-Rañada JM.
    Bone Marrow Transplant; 1997 Feb 15; 19(4):331-6. PubMed ID: 9051242
    [Abstract] [Full Text] [Related]

  • 15. High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
    Laport GF, Grad G, Grinblatt DL, Bitran JD, Williams SF.
    Bone Marrow Transplant; 1998 Jan 15; 21(2):127-32. PubMed ID: 9489628
    [Abstract] [Full Text] [Related]

  • 16. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies.
    Demirer T, Ilhan O, Mandel NM, Arat M, Günel N, Celebi H, Ustün C, Akan H, Demirer S, Aydintuğ S, Uysal A, Koç H.
    Bone Marrow Transplant; 2000 Apr 15; 25(7):697-703. PubMed ID: 10745253
    [Abstract] [Full Text] [Related]

  • 17. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.
    Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN, Brodsky I, Martino S, Lazarus HM, Erban JK, Sickles C, Glick JH.
    N Engl J Med; 2000 Apr 13; 342(15):1069-76. PubMed ID: 10760307
    [Abstract] [Full Text] [Related]

  • 18. Phase II pilot study of high-dose busulfan and CY followed by autologous BM or peripheral blood stem cell transplantation in patients with advanced chemosensitive breast cancer.
    Klumpp TR, Mangan KF, Glenn LD, Macdonald JS.
    Bone Marrow Transplant; 1993 Apr 13; 11(4):337-9. PubMed ID: 8097937
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.